Mirum Pharmaceuticals Inc (MIRM)
25.84
+0.24
(+0.94%)
USD |
NASDAQ |
May 03, 16:00
25.82
-0.02
(-0.08%)
After-Hours: 20:00
Mirum Pharmaceuticals Cash from Operations (Quarterly): -16.62M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -16.62M |
| September 30, 2023 | -18.22M |
| June 30, 2023 | -2.331M |
| March 31, 2023 | -33.77M |
| December 31, 2022 | -34.27M |
| September 30, 2022 | -26.02M |
| June 30, 2022 | -20.17M |
| March 31, 2022 | -39.67M |
| December 31, 2021 | -33.15M |
| September 30, 2021 | -34.20M |
| Date | Value |
|---|---|
| June 30, 2021 | -40.20M |
| March 31, 2021 | -25.21M |
| December 31, 2020 | -36.28M |
| September 30, 2020 | -17.45M |
| June 30, 2020 | -16.99M |
| March 31, 2020 | -18.35M |
| December 31, 2019 | -13.70M |
| September 30, 2019 | -15.22M |
| June 30, 2019 | -8.017M |
| March 31, 2019 | -2.426M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-40.20M
Minimum
Jun 2021
-2.331M
Maximum
Jun 2023
-23.68M
Average
-20.17M
Median
Jun 2022
Cash from Operations (Quarterly) Benchmarks
| Vanda Pharmaceuticals Inc | -3.732M |
| Sarepta Therapeutics Inc | -242.08M |
| Puma Biotechnology Inc | 10.46M |
| Reneo Pharmaceuticals Inc | -19.75M |
| Tharimmune Inc | -1.415M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -2.00M |
| Cash from Financing (Quarterly) | 1.777M |
| Free Cash Flow | -91.05M |
| Free Cash Flow Per Share (Quarterly) | -0.4637 |
| Free Cash Flow to Equity (Quarterly) | -22.02M |
| Free Cash Flow to Firm (Quarterly) | -21.62M |
| Free Cash Flow Yield | -8.62% |